4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-009180
Chief Commercial Officer acquired 18,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Olinger Margaret Chief Commercial Officer | 2023-03-16 | Grant or award | +18,333 | 232,688 | D | ||
| Derivatives | |||||||
| Olinger Margaret Chief Commercial Officer | 2023-03-16 | Grant or award · Stock Option (right to buy) | +82,500 | 82,500 | D | ||
Loading xslF345X04/doc4.xml…